Abstract
The WT1 gene is an important oncogene, and its overexpression is considered as an effective target for anticancer therapy. Regulation of its gene transcription is one way for WT1-targeting drug design. Recently, in silico analysis of some oncogene promoters like WT1 showed some guanine-rich regions with the ability to form G-quadruplex structures. Ligands like 5,10,15,20-tetra(N-methyl-4-pyridyl)-porphine (TMPyP4) have predominant effect on G-quadruplex stabilization. The aim of this study was to understand the effect of TMPyP4 on WT1 gene transcription via stabilization of promoter G-quadruplexes. We examined the formation of new G-quadruplex motifs in WT1 promoter in the presence of TMPyP4. In order to understand the nature of its interaction with WT1 promoter quadruplexes, differential pulse voltammetry (DPV), circular dichroism (CD), polyacrylamide gel electrophoresis, electrophoretic mobility shift assay (EMSA), polymerase chain reaction (PCR) stop assays, and quantitative RT-PCR were performed. According to the results, the WT1 promoter can form stable intramolecular parallel G-quadruplexes. In addition, after 48 and 96 h of incubation, 100 μM TMPyP4 reduced the WT1 transcription to 9 and 0.4 %, respectively, compare to control. We report that ligand-mediated stabilization of G-quadruplexes within the WT1 promoter can silence WT1 expression. This study might offer the basis for the reasonable design and improvement of new porphyrin derivatives as effective anti-leukemia agents for cancer therapy.
Similar content being viewed by others
References
Yang D, Okamoto K. Structural insights into G-quadruplexes: towards new anticancer drugs. Future Med Chem. 2010;2:619–46.
Punchihewa C, Yang D. Therapeutic targets and drugs II: G-quadruplex and G-quadruplex inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. Totowa: Humana Press; 2009.
Qin Y, Hurley LH. Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions. Biochimie. 2008;90:1149–71. doi:10.1016/j.biochi.2008.02.020.
Kumari S, Bugaut A, Huppert JL, Balasubramanian S. An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translation. Nat Chem Biol. 2007;3:218–21. doi:10.1038/nchembio864.
Gehring K, Leroy JL, Guéron MA. Tetrameric DNA structure with protonated cytosine-cytosine base pairs. Nature. 1993;363:499–510. doi:10.1038/363561a0.
Engelhart AE, Plavec J, Persil, O, Hud, NV. Metal ion interactions with G-quadruplex structures. Nucleic Acid–Metal Ion Interactions. RSC Publishing; 2008. p. 118–147.
Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci. 2002;99:11593–8. doi:10.1073/pnas.182256799.
Sun D, Guo K, Rusche JJ, Hurley LH. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Res. 2005;33:6070–80. doi:10.1093/nar/gki917.
De Armond R, Wood S, Sun D, Hurley LH, Ebbinghaus SW. Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1α promoter. Biochemistry. 2005;44:16341–50. doi:10.1021/bi051618u.
Rankin S, Reszka AP, Huppert J, Zloh M, Parkinson GN, Todd AK, et al. Putative DNA quadruplex formation within the human c-kit oncogene. J Am Chem Soc. 2005;127:10584–9. doi:10.1021/ja050823u.
Fernando H, Reszka AP, Huppert J, Ladame S, Rankin S, Venkitaraman AR, et al. A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene. Biochemistry. 2006;45:7854–60. doi:10.1021/bi0601510.
Rosenfeld C, Cheever MA, Gaiger A. WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia. 2003;17:1301–12. doi:10.1038/sj.leu.2402988.
Neidle S, Balasubramanian S. Quadruplex nucleic acids. Eds. Royal Society of Chemistry. Cambridge, UK; 2006.
Patel DJ, Phan AT, Kuryavyi V. Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res. 2007;35:7429–55. doi:10.1093/nar/gkm711.
Ren J, Chaires JB. Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry. 1999;38:16067–75.
Grand CL, Han H, Muñoz RM, Weitman S, Von Hoff DD, Hurley LH, et al. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Mol Cancer Ther. 2002;1:565–73.
Qin Y, Rezler EM, Gokhale V, Sun D, Hurley LH. Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4. Nucleic Acids Res. 2007;3:7698–713. doi:10.1093/nar/gkm538.
del Toro M, Bucek P, Aviñó A, Jaumot J, González C, Eritja R, et al. Targeting the G-quadruplex-forming region near the P1 promoter in the human BCL-2 gene with the cationic porphyrin TMPyP4 and with the complementary C-rich strand. Biochimie. 2009;91:894–902. doi:10.1016/j.biochi.2009.04.012.
Nagesh N, Buscaglia R, Dettler JM, Lewis EA. Studies on the site and mode of TMPyP4 interactions with Bcl-2 promoter sequence G-quadruplexes. Biophys J. 2010;98:2628–33. doi:10.1016/j.bpj.2010.02.050.
Manaye S, Eritja R, Aviñó A, Jaumot J, Gargallo R. Porphyrin binding mechanism is altered by protonation at the loops in G-quadruplex DNA formed near the transcriptional activation site of the human c-kit gene. Biochim Biophys Acta Gen Subj. 2012;1820:1987–96. doi:10.1016/j.bbagen.2012.09.006.
Cogoi S, Xodo LE. G-quadruplex formation within the promoter of the K-RAS proto-oncogene and its effect on transcription. Nucleic Acids Res. 2006;34:2536–49. doi:10.1093/nar/gkl286.
Zidanloo SG, Hosseinzadeh Colagar A. Geographic heterogeneity of the AML1-ETO fusion gene in Iranian patients with acute myeloid leukemia. RBMB. 2014;3:1–7.
Shen H, Xu W, Wu Z, Tang H, Xie Y, Zhong X. Down-regulation of WT1/+ 17AA gene expression using RNAi and modulating leukemia cell chemotherapy resistance. Haematologica. 2007;92:1270–2.
Glienke W, Maute L, Koehl U, Esser R, Milz E, Bergmann L. Effective treatment of leukemic cell lines with wt1 siRNA. Leukemia. 2007;21:2164–70. doi:10.1038/sj.leu.2404878.
Liu Y, Qu X, Wang P, Tian X, Luo Y, Liu S, et al. WT1 downregulation during K562 cell differentiation and apoptosis induced by bufalin. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2002;23:356–9.
Zapata-Benavides P, Tuna M, Lopez-Berestein G, Tari AM. Downregulation of Wilms’ tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun. 2002;295:784–90. doi:10.1016/S0006-291X(02)00751-9.
Navakanit R, Graidist P, Leeanansaksiri W, Dechsukum C. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene. J Med Assoc Thai. 2007;90:2416–21.
Clark AJ, Chan DC, Chen MY, Fillmore H, Dos Santos WG, Van Meter TE, et al. Down-regulation of Wilms’ tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53. J Neurooncol. 2007;83:163–72.
Zamora-Avila DE, Franco-Molina MA, Trejo-Avila LM, Rodríguez-Padilla C, Resendez-Perez D, Zapata-Benavides P. RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line. Melanoma Res. 2007;17:341–8. doi:10.1097/CMR.0b013e3282efd3ae.
Wagner N, Panelos J, Massi D, Wagner KD. The Wilms’ tumor suppressor WT1 is associated with melanoma proliferation. Pflugers Arch. 2008;455:839–47. doi:10.1007/s00424-007-0340-1.
Weisser M, Kern W, Rauhut S, Schoch C, Hiddemann W, Haferlach T, et al. Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia. Leukemia. 2005;19:1416–23. doi:10.1038/sj.leu.2403809.
Zhang R, Lin Y, Zhang CT. Greglist: a database listing potential G-quadruplex regulated genes. Nucleic Acids Res. 2008;36:D372–6. doi:10.1093/nar/gkm787.
Fraizer GC, Wu YJ, Hewitt SM, Maity T, Ton CC, Huff V, et al. Transcriptional regulation of the human Wilms’ tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. J Biol Chem. 1994;269:8892–900.
Lemarteleur T, Gomez D, Paterski R, Mandine E, Mailliet P, Riou JF. Stabilization of the c-myc gene promoter quadruplex by specific ligands’ inhibitors of telomerase. Biochem Biophys Res Commun. 2004;323:802–8. doi:10.1016/j.bbrc.2004.08.150.
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988;48:589–601.
Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia. 2002;16:2115–21. doi:10.1038/sj.leu.2402675.
Provencio I, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD. A novel human opsin in the inner retina. J Neurosci. 2000;20:600–5.
Green MR, Sambrook J. Molecular cloning a laboratory manual. 4th ed. New York: Cold Spring Harbor Laboratory Press; 2012.
Kikin O, D’Antonio L, Bagga PS. QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res. 2006;34:W676–82. doi:10.1093/nar/gkl253.
Chiorcea-Paquim AM, Santos PV, Eritja R, Oliveira-Brett AM. Self-assembled G-quadruplex nanostructures: AFM and voltammetric characterization. Phys Chem Chem Phys. 2013;15:9117–24. doi:10.1039/c3cp50866h.
Miyoshi D, Nakao A, Sugimoto N. Structural transition from antiparallel to parallel G-quadruplex of d(G4T4G4) induced by Ca2+. Nucleic Acids Res. 2003;31:1156–63.
Hurley LH. Secondary DNA, structures as molecular targets for cancer therapeutics. Biochem Soc Trans. 2001;29:692–6. doi:10.1042/bst0290692.
Sun D, Liu WJ, Guo K, Rusche JJ, Ebbinghaus S, Gokhale V, et al. The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents. Mol Cancer Ther. 2008;7:880–9. doi:10.1158/1535-7163.MCT-07-2119.
Han H, Langley DR, Rangan A, Hurley LH. Selective interactions of cationic porphyrins with G-quadruplex structures. J Am Chem Soc. 2001;123:8902–13. doi:10.1021/ja002179j.
Taka T, Joonlasak K, Huang L, Randall Lee T, Chang SW, Tuntiwechapikul W. Down-regulation of the human VEGF gene expression by perylene monoimide derivatives. Bioorg Med Chem Lett. 2012;22:518–22. doi:10.1016/j.bmcl.2011.10.089.
Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994;84:3071–9.
Dailey L, Hanly SM, Roeder RG, Heintz N. Distinct transcription factors bind specifically to two regions of the human histone H4 promoter. Proc Natl Acad Sci U S A. 1986;83:7241–5.
Dailey L, Roberts SB, Heintz N. Purification of the human histone H4 gene-specific transcription factors H4TF-1 and H4TF-2. Genes Dev. 1988;2:1700–12. doi:10.1101/gad.2.12b.1700.
Nakken S, Rognes T, Hovig E. The disruptive positions in human G-quadruplex motifs are less polymorphic and more conserved than their neutral counterparts. Nucleic Acids Res. 2009;37:5749–56. doi:10.1093/nar/gkp590.
Huppert JL. Hunting G-quadruplexes. Biochimie. 2008;90:1140–8. doi:10.1016/j.biochi.2008.01.014.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Rights and permissions
About this article
Cite this article
Zidanloo, S.G., Hosseinzadeh Colagar, A., Ayatollahi, H. et al. Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells. Tumor Biol. 37, 9967–9977 (2016). https://doi.org/10.1007/s13277-016-4881-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-016-4881-9